Delivery Order SPE2DB22D3501-SPE2DB25FXJ55
- Not listed
- The Defense Logistics Agency awarded a $103,639.49 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in treating acromegaly and neuroendocrine tumors. This firm fixed price delivery order, issued on September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This firm fixed-price delivery order, valued at $48,386.59, represents a competitive award with no set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $75,895.87 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. The contract, executed on May 12, 2025, with an ultimate completion date of May 13, 2025, represents a firm fixed-price delivery under a competitive procurement with no set-aside designation. AmerisourceBergen's Conshohocken, Pennsylvania facility serves as the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $50,215.83 on July 14, 2025, for the supply of Sandostatin LAR Depot 30 mg kits. This competitively awarded, firm fixed-price contract carries an ultimate completion date of July 15, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain, which serves the Department of Defense healthcare requirements. The award represents a...
- The Defense Logistics Agency awarded a $12,832.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Sandostatin LAR Depot 30 mg kits. Scheduled for completion by September 17, 2025, this firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Sandostatin LAR Depot 20 mg kits valued at $62,713.64 with firm fixed pricing. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a $20,091.40 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price contract, awarded on August 1, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $8,146.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 22, 2025. This non-set-aside award represents a competitive procurement executed on August 21, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $26,598.20 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXJ55Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,639.28 delivery order on September 17, 2025, for Sandostatin LAR Depot 20 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This competitively awarded, firm fixed-price contract represents an individual delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's DLA Troop Support Medical IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. As a child contract under this prime IDV, this delivery order exemplifies AmerisourceBergen's ongoing role in fulfilling specialized pharmaceutical requirements for the Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/17/25 |